The Aberdeen-based company also said in was in “active discussions to out-licence” the clinical development of its product.
Novexatin has been proven so far to rapidly clear fungal nail infection.
- Text size
NovaBiotics prepares to out-licence nail product
Novabiotics, the Scottish biotechnology company focused on the design and development of antifungal and antibacterial therapies, successfully completed the dosing initial analysis of its phase IIa clinical trials for Novexatin, a brush-on treatment for fungal nail infection.
